Navigation

ExploreAnalysisInvestor RelationsAI AssistantCompareScreener
LoginSign Up FreeSign Up

© 2026 MarketCI. All rights reserved.

HelpPricingPrivacyTerms
MR

MRK

Market Closed

Merck & Co., Inc.

NYSEHealthcareDrug Manufacturers - General
US
74.00K employees
CEO: Robert Davis
Founded: 1978
$145.83
+$0.00(+NaN%)
Market Cap
359.51B
Beta
0.22
52W Range
N/A
Dividend Yield
2.33%
OverviewForecastsFundamentalMarket SentimentValuationOwnership
OverviewForecastsFundamentalMarket SentimentValuationOwnership
Comprehensive Valuation
In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Merck's current price near fair value with modest 2.2% upside and high-confidence valuations signals limited immediate upside. Strong profitability and efficiency offset moderate growth and leverage risks, while Monte Carlo shows significant volatility and notable downside scenarios (52.8%). The broad value range reflects uncertainty driven by varying WACC and growth assumptions.
Enhanced Football Field Analysis
Loading comprehensive valuation data...

Fetching multi-methodology valuation ranges...

Explore MRK

Overview

Key metrics and AI-powered insights

Forecast

Price targets and earnings estimates

Fundamentals

Income, balance sheet and cash flow

Valuation

P/E, DCF and valuation multiples

Ownership

Institutional and insider holdings

Sentiment

Analyst ratings and news sentiment

MRK in the Healthcare

Mega Cap
Healthcare

Browse sector stocks →

Drug Manufacturers - General

Browse industry stocks →